Search
for
Sort by
Research 181–210 of 1000+
- Interventions for morphea
- 17β-estradiol Inhibits the Production of RANTES in Human Keratinocytes
- Glucocorticoid and Sex Hormone Receptors: Clinical Implications and Therapeutic Relevance
- Inflammatory Skin Disease in Latin America: Treatment Challenges and Opportunities
- Smart Biomaterials and Dressings for the Treatment of Chronic Inflammatory Skin Diseases
- The Impact of Immune-Modifying Treatments for Skin Diseases on the Immune Response to COVID-19 Vaccines: a Narrative Review
- Risk of Autoimmune Skin Diseases Associated With Immune Checkpoint Inhibitors: A Pharmacovigilance Analysis Using the FAERS Database
- Dupilumab in Inflammatory Skin Diseases: A Systematic Review
- Regulatory T cells in skin
- 915 Dietary grape powder inhibits atopic dermatitis-like skin lesions in NC/Nga mice
- Immunological control of skin development: from homeostasis to developmental pathologies
- Immune modulation of hair follicle regeneration
- Aging Skin: A Window to the Body
- Nanotechnological reprogramming of the pathological skin microenvironment in scar formation and atopic dermatitis
- Unraveling the ECM-Immune Cell Crosstalk in Skin Diseases
- Physiological Doses of Red Light Induce IL‐4 Release in Cocultures between Human Keratinocytes and Immune Cells
- Surface Lipids as Multifunctional Mediators of Skin Responses to Environmental Stimuli
- Gender differences in skin: A review of the literature
- Exploring Mast Cell–CD8 T Cell Interactions in Inflammatory Skin Diseases
- Immune-Molecular Link between Thyroid and Skin Autoimmune Diseases: A Narrative Review
- The orchestrated network of skin photoaging: From intercellular crosstalk to molecular signaling
- Tyrosine Kinases in Autoimmune and Inflammatory Skin Diseases
- Implication of Human Bacterial Gut Microbiota on Immune-Mediated and Autoimmune Dermatological Diseases and Their Comorbidities: A Narrative Review
- Tofacitinib Loaded Squalenyl Nanoparticles for Targeted Follicular Delivery in Inflammatory Skin Diseases
- Mitochondrial dysfunction in metabolic syndrome and inflammatory skin disease
- Insulin Resistance, Metabolic Syndrome, and Inflammatory Skin Disease
- Non‐biologic immunosuppressive drugs for inflammatory and autoimmune skin diseases
- Major clinical outcomes of the gut microbiota-skin axis through exosomes and probiotics: a systematic review
- Microneedle-Mediated Transdermal Drug Delivery for the Treatment of Multiple Skin Diseases
- Can Platelet-Rich Plasma Reduce the Burden of Inflammatory Skin Diseases Such as Psoriasis and Atopic Dermatitis?